Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

CG Oncology (CGON) Return on Equity (2024 - 2025)

Historic Return on Equity for CG Oncology (CGON) over the last 2 years, with Q3 2025 value amounting to 0.22%.

  • CG Oncology's Return on Equity fell 900.0% to 0.22% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.22%, marking a year-over-year decrease of 900.0%. This contributed to the annual value of 0.29% for FY2024, which is N/A changed from last year.
  • CG Oncology's Return on Equity amounted to 0.22% in Q3 2025, which was down 900.0% from 0.19% recorded in Q2 2025.
  • CG Oncology's 5-year Return on Equity high stood at 0.11% for Q2 2024, and its period low was 0.25% during Q1 2024.